The treatment progress of the oral lichen planus

doi:10.3877/cma.j.issn.1674-1366.2022.04.001

Abstract

Abstract:

Oral lichen planus (OLP) is a chronic inflammatory disease of oral mucosa with complex etiology, which belongs to the category of oral potential malignant disorders. At present, drug therapy is the main treatment of OLP. Although a variety of new immunosuppressive agents are widely used in OLP treatment, some cases are still difficult to treat and easy to relapse, and a few cases end up with malignant transformation. Exploring new therapeutic drugs and methods is the key to solve the current dilemma. With the development of modern biotechnology and medical equipment, the biological agents, photodynamic therapy and photobiomodulation therapy are gradually applied to the clinical treatment of OLP. This article reviews the recent literature and provides a brief overview of the treatment progress of OLP.

Key words: Lichen planus, oral, Drug therapy, Immunosuppressive agents, Physical therapy modalities, Psychotherapy

Xijuan Chen, Juan Xia. The treatment progress of the oral lichen planus[J]. Chinese Journal of Stomatological Research(Electronic Edition), 2022, 16(04): 203-207.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhkqyxyjzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-1366.2022.04.001

https://zhkqyxyjzz.cma-cmc.com.cn/EN/Y2022/V16/I04/203

References 34

[1]	中华口腔医学会口腔黏膜病学专业委员会，中华口腔医学会中西医结合专业委员会.口腔扁平苔藓诊疗指南（修订版）[J].中华口腔医学杂志，2022，57（2）：115-121. DOI：10.3760/cma.j.cn112144-20211115-00505.
[2]	Su Z，Hu J，Cheng B，et al. Efficacy and safety of topical administration of tacrolimus in oral lichen planus：An updated systematic review and meta-analysis of randomized controlled trials[J]. J Oral Pathol Med，2022，51（1）：63-73. DOI：10.1111/jop.13217.
[3]	Ladda M，Sandhu V，Ighani A，et al. Off-label uses of topical pimecrolimus[J]. J Cutan Med Surg，2019，23（4）：442-448. DOI：10.1177/1203475419847950.
[4]	da Silva EL，de Lima TB，Rados PV，et al. Efficacy of topical non-steroidal immunomodulators in the treatment of oral lichen planus：A systematic review and meta-analysis[J]. Clin Oral Investig，2021，25（9）：5149-5169. DOI：10.1007/s00784-021-04072-7.
[5]	刘晓慧，刘永红，张晓光，等.康复新液与他克莫司联合沙利度胺治疗口腔扁平苔藓的疗效及安全性分析[J].现代生物医学进展，2020，20（15）：2971-2974. DOI：10.13241/j.cnki.pmb.2020.15.035.
[6]	Wu Y，Zhou G，Zeng H，et al. A randomized double-blind，positive-control trial of topical thalidomide in erosive oral lichen planus[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod，2010，110（2）：188-195. DOI：10.1016/j.tripleo.2010.03.034.
[7]	Lajevardi V，Ghodsi SZ，Hallaji Z，et al. Treatment of erosive oral lichen planus with methotrexate[J]. J Dtsch Dermatol Ges，2016，14（3）：286-293. DOI：10.1111/ddg.12636.
[8]	Husein-ElAhmed H，Gieler U，Steinhoff M. Lichen planus：A comprehensive evidence-based analysis of medical treatment[J]. J Eur Acad Dermatol Venereol，2019，33（10）：1847-1862. DOI：10.1111/jdv.15771.
[9]	苏秋霞.他克莫司软膏联合胸腺肽治疗慢性乙型肝炎合并口腔扁平苔藓的疗效及对患者免疫功能的影响[J].内科，2018，13（4）：599-602. DOI：10.16121/j.cnki.cn45-1347/r.2018.04.18.
[10]	Salehi B，Lopez-Jornet P，Pons-Fuster López E，et al. Plant-derived bioactives in oral mucosal lesions：A key emphasis to curcumin，lycopene，chamomile，aloe vera，green tea and coffee properties[J]. Biomolecules，2019，9（3）：106. DOI：10.3390/biom9030106.
[11]	Ghahremanlo A，Boroumand N，Ghazvini K，et al. Herbal medicine in oral lichen planus[J]. Phytother Res，2019，33（2）：288-293. DOI：10.1002/ptr.6236.
[12]	Luo Y，Kuai L，Chen J，et al. Efficacy and safety of Tripterygium wilfordii Hook. f. for oral lichen planus：Evidence from 18 randomized controlled trials[J]. Phytother Res，2020，34（9）：2180-2191. DOI：10.1002/ptr.6672.
[13]	Nasr MM，Ebrahim HM，Khattab FM，et al. Bacillus calmette-guerin，polysaccharide nucleic acid in the treatment of cutaneous and oral lichen planus[J]. Dermatol Ther，2018，31（3）：e12591. DOI：10.1111/dth.12591.
[14]	Balestri R，Bortolotti R，Rech G，et al. Treatment of oral erosive lichen planus with upadacitinib[J]. JAMA Dermatol，2022，158（4）：457-458. DOI：10.1001/jamadermatol.2022.0147.
[15]	Moussa A，Colla T，Morrison B，et al. Effective treatment of oral lichen planus with the JAK inhibitor baricitinib[J]. Australas J Dermatol，2022，63（2）：276-277. DOI：10.1111/ajd.13811.
[16]	孙雨桐，江潞.生物制剂在口腔扁平苔藓治疗中的应用[J].口腔医学，2022，42（3）：261-265. DOI：10.13591/j.cnki.kqyx.2022.03.014.
[17]	Mahmoud MM，Afifi MM. Anti-angiogenic therapy（bevacizumab）in the management of oral lichen planus[J]. Eur J Oral Sci，2016，124（2）：119-126. DOI：10.1111/eos.12251.
[18]	Jiang H，Li J，Wang L，et al. Total glucosides of paeony：A review of its phytochemistry，role in autoimmune diseases，and mechanisms of action[J]. J Ethnopharmacol，2020，258：112913. DOI：10.1016/j.jep.2020.112913.
[19]	娄依婷，陶然，李勇正，等.基于网络药理学研究白芍总苷治疗口腔扁平苔癣的作用机制[J].中成药，2022，44（3）：1005-1010. DOI：10.3969/j.issn.1001-1528.2022.03.060.
[20]	李梅.他克莫司软膏与白芍总苷治疗口腔扁平苔藓的临床疗效分析[J].实用临床医药杂志，2016，20（19）：152-153. DOI：10.7619/jcmp.201619056.
[21]	Hashem AS，Issrani R，Elsayed TEE，et al. Topical hyaluronic acid in the management of oral lichen planus：A comparative study[J]. J Investig Clin Dent，2019，10（2）：e12385. DOI：10.1111/jicd.12385.
[22]	Agha-Hosseini F，Atyabi F，Akbari K，et al. Decreased recurrence of symptoms in oral lichen planus with intralesional injection of hyaluronic acid and triamcinolone[J]. Int J Oral Maxillofac Surg，2021，50（12）：1643-1648. DOI：10.1016/j.ijom.2021.02.028.
[23]	Zanetta P，Ormelli M，Amoruso A，et al. Probiotics as potential biological immunomodulators in the management of oral lichen planus：What′s new？[J]. Int J Mol Sci，2022，23（7）：3489. DOI：10.3390/ijms23073489.
[24]	Han X，Zhang J，Tan Y，et al. Probiotics：A non-conventional therapy for oral lichen planus[J]. Arch Oral Biol，2017，81：90-96. DOI：10.1016/j.archoralbio.2017.04.026.
[25]	Keller MK，Kragelund C. Randomized pilot study on probiotic effects on recurrent candidiasis in oral lichen planus patients[J]. Oral Dis，2018，24（6）：1107-1114. DOI：10.1111/odi.12858.
[26]	Li Y，Shao F，Zheng S，et al. Alteration of Streptococcus salivarius in buccal mucosa of oral lichen planus and controlled clinical trial in OLP treatment[J]. Probiotics Antimicrob Proteins，2020，12（4）：1340-1348. DOI：10.1007/s12602-020-09664-5.
[27]	Marlina E，Goodman RN，Mercadante V，et al. A proof of concept pilot trial of probiotics in symptomatic oral lichen planus （CABRIO）[J]. Oral Dis，2021. DOI：10.1111/odi.14014.
[28]	Al-Hallak N，Hamadah O，Mouhamad M，et al. Efficacy of injectable platelet-rich fibrin in the treatment of symptomatic oral lichen planus[J]. Oral Dis，2022. DOI：10.1111/odi.14261.
[29]	He Y，Deng J，Zhao Y，et al. Efficacy evaluation of photodynamic therapy for oral lichen planus：A systematic review and meta-analysis[J]. BMC Oral Health，2020，20（1）：302. DOI：10.1186/s12903-020-01260-x.
[30]	Wang B，Fan J，Wang L，et al. Photobiomodulation therapy/photodynamic therapy versus steroid therapy for oral lichen planus：A systematic review and meta-analysis[J]. Photobiomodul Photomed Laser Surg，2021，39（3）：145-154. DOI：10.1089/photob.2020.4930.
[31]	Amanat D，Ebrahimi H，Zahedani MZ，et al. Comparing the effects of cryotherapy with nitrous oxide gas versus topical corticosteroids in the treatment of oral lichen planus[J]. Indian J Dent Res，2014，25（6）：711-716. DOI：10.4103/0970-9290.152166.
[32]	戈春城，童国勇，徐佳.口腔修复膜在手术治疗口腔扁平苔藓中的疗效评价[J].临床口腔医学杂志，2015，31（6）：350-351. DOI：10.3969/j.issn.1003-1634.2015.06.012.
[33]	Tarasenko S，Stepanov M，Morozova E，et al. High-level laser therapy versus scalpel surgery in the treatment of oral lichen planus：A randomized control trial[J]. Clin Oral Investig，2021，25（10）：5649-5660. DOI：10.1007/s00784-021-03867-y.
[34]	Li K，He W，Hua H. Characteristics of the psychopathological status of oral lichen planus：A systematic review and meta-analysis[J]. Aust Dent J，2022，67（2）：113-114. DOI：10.1111/adj.12896.

Please choose a citation manager

Content to export